Aspire Biopharma Holdings, Inc. (ASBP)
NASDAQ: ASBP · Real-Time Price · USD
0.4301
-0.1723 (-28.60%)
At close: May 30, 2025, 4:00 PM
0.4156
-0.0145 (-3.37%)
After-hours: May 30, 2025, 7:59 PM EDT

Aspire Biopharma Holdings Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22
Selling, General & Admin
2.011.070.290.42
Research & Development
0.40.140.070.18
Operating Expenses
2.411.210.360.6
Operating Income
-2.41-1.21-0.36-0.6
Interest Expense
-0.39-0.1--
Pretax Income
-17.02-1.31-0.36-0.6
Income Tax Expense
0000
Net Income
-17.02-1.31-0.36-0.6
Net Income to Common
-17.02-1.31-0.36-0.6
Shares Outstanding (Basic)
49440443-
Shares Outstanding (Diluted)
49440443-
Shares Change (YoY)
77.18%-0.68%--
EPS (Basic)
-0.35-0.00-0.00-
EPS (Diluted)
-0.35-0.00-0.00-
EBIT
-2.41-1.21-0.36-0.6
Updated Jan 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.